Skip to content

Functional vascular analyzis for prediction of pre-eclampsia

Functional vascular analyzis for prediction of pre-eclampsia - VASPRE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024904
Enrollment
170
Registered
2021-04-20
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

O14 O36.5

Interventions

Group 1: Pregnant women at risk for development of pre-eclampsia get repeated analyses of the peripheral and retinal arterial vessels by peripheral arterial tonometry (EndoPAT) and Dynamic Vessel Anal

Sponsors

Universitätsfrauenklinik und Poliklinik am Klinikum Südstadt Rostock
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: pregravid obesity (body mass index equal or greater 30 kg/squaremeters befor pregnancy) and/or mean pulsatility index (PI) of the uterine arteries greater than 95. centile

Exclusion criteria

Exclusion criteria: person not capable of giving consent, no informed consent, intrauterine fetal death, chromosomal aberrations, severe fetal malformations, premature preterm rupture of membranes, known anti-phospholipid syndrome, history of pre-eclampsia or pregnancy induced hypertension in a previous pregnancy, multiple gestation, chronic kidney disease, diabetes mellitus type 1, eye diseased of diagnostic relevance: cloudiness of the optical media, missing adherence, relevant diseases of the cornea and retina, existence of at least one of the following lab criterions at time point of study inclusion: creatinine = 90µmol/l, proteinuria = 300mg/d, protein creatinine ratio = 0,3 mg/mg or u-stick > 1+, ALT/AST > 40 IU/l resp. >0,67µkat/l, platelets < 150 x 10^9/l.

Design outcomes

Primary

MeasureTime frame
Development of pre-eclampsia (in accordance to ISSHP criterions)

Secondary

MeasureTime frame
Development of pregnancy induced arterial hypertension (in accordance to ISSHP criterions) or intrauterine growth restriction in accordance to the German guideline.

Countries

Germany

Contacts

Public ContactJohannes Stubert

Universitätsfrauenklinik und Poliklinik am Klinikum Südstadt Rostock

johannes.stubert@uni-rostock.de038144018475

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026